3-Iodo-6-methylimidazo[1,2-a]pyridine(CAS: 885276-23-3)

3-Iodo-6-methylimidazo[1,2-a]pyridine (CAS: 885276-23-3) is subject to various regulatory guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA requirements for chemical safety and environmental impact assessments. Manufacturers and handlers must comply with these guidelines to ensure safety and regulatory compliance.

Alternatives to 3-Iodo-6-methylimidazo[1,2-a]pyridine (CAS: 885276-23-3) in synthesis include other iodo-substituted imidazo[1,2-a]pyridine derivatives, such as 3-bromo-6-methylimidazo[1,2-a]pyridine, which can serve as functional equivalents in many chemical reactions. Researchers often explore these alternatives to find the most efficient and environmentally friendly routes.

The market for 3-Iodo-6-methylimidazo[1,2-a]pyridine (CAS: 885276-23-3) is expanding due to its applications in pharmaceutical research, particularly as a potential antiviral and antitumor agent. Research trends focus on exploring its efficacy in drug development and understanding its mechanisms. Additionally, market interest is driven by its use in academic studies on medicinal chemistry and synthetic methods.

Waste containing 3-Iodo-6-methylimidazo[1,2-a]pyridine (CAS: 885276-23-3) should be collected in sealed, leak-proof containers and stored in a secure location. It should be disposed of through a professional hazardous waste disposal service that complies with local, state, and federal regulations. Environmental protection measures include proper labeling, minimizing exposure, and ensuring no contamination of soil or water sources.